Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam C Calaway

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Urologic Oncology|November 29, 2020
Evaluating the impact of minimally invasive vs open trials in urologic malignancy. Are we missing the mark?Ronald S Boris, Adam C Calaway
The Canadian Journal of Urology|December 9, 2014
Spontaneous resolution of inflammatory myofibroblastic tumor of the kidneyAdam C Calaway, Dibson Gondim, Muhammad Idrees, et al.
Journal of Endourology Case Reports|September 1, 2016
Getting Out of a PCCL: Percutaneous Cholecystolithotomy as a Salvage Treatment Option for Gallstone Removal in Patients Deemed Unfit for Standard Surgical ApproachesAdam C Calaway, Michael S Borofsky, Casey A Dauw, et al.
The Urologic Clinics of North America|November 21, 2020
Historical Considerations and Surgical Quality Improvement in Robotic ProstatectomyDanly O Omil-Lima, Karishma Gupta, Adam C Calaway, et al.
The Canadian Journal of Urology|August 13, 2015
Robot-assisted renal tumor enucleo-resection in patients with a solitary kidneyAdam C Calaway, Gopal N Gupta, Akshay Bhandar, et al.
Urologic Oncology|May 26, 2020
Postchemotherapy retroperitoneal lymph node dissection in patients presenting with very high HCG levelsRyan W Speir, Adam C Calaway, Lawrence H Einhorn, et al.
European Urology|August 25, 2019
Reply to Gregory J. Nason, Michael A.S. Jewett, and Robert J. Hamilton's Letter to the Editor re: Adam C. Calaway, Lawrence H. Einhorn, Timothy A. Masterson, Richard S. Foster, Clint Cary. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer. Eur Urol 2019;76:607-609: Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular CancerAdam C Calaway, Lawrence H Einhorn, Timothy A Masterson, et al.
Urologic Oncology|October 3, 2018
A novel preoperative model to predict 90-day surgical mortality in patients considered for renal cell carcinoma surgeryAdam C Calaway, M Francesca Monn, Clinton D Bahler, et al.
European Urology|June 9, 2019
Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular CancerAdam C Calaway, Lawrence H Einhorn, Timothy A Masterson, et al.
Urologic Oncology|February 1, 2020
Improving postoperative quality of care in germ cell tumor patients: Does scheduled alvimopan, acetaminophen, and gabapentin improve short-term clinical outcomes after retroperitoneal lymph node dissection?Adam C Calaway, Richard S Foster, Yan Tong, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Urologic Oncology|November 29, 2020
Evaluating the impact of minimally invasive vs open trials in urologic malignancy. Are we missing the mark?Ronald S Boris, Adam C Calaway
The Canadian Journal of Urology|December 9, 2014
Spontaneous resolution of inflammatory myofibroblastic tumor of the kidneyAdam C Calaway, Dibson Gondim, Muhammad Idrees, et al.
Journal of Endourology Case Reports|September 1, 2016
Getting Out of a PCCL: Percutaneous Cholecystolithotomy as a Salvage Treatment Option for Gallstone Removal in Patients Deemed Unfit for Standard Surgical ApproachesAdam C Calaway, Michael S Borofsky, Casey A Dauw, et al.
The Urologic Clinics of North America|November 21, 2020
Historical Considerations and Surgical Quality Improvement in Robotic ProstatectomyDanly O Omil-Lima, Karishma Gupta, Adam C Calaway, et al.
The Canadian Journal of Urology|August 13, 2015
Robot-assisted renal tumor enucleo-resection in patients with a solitary kidneyAdam C Calaway, Gopal N Gupta, Akshay Bhandar, et al.
Urologic Oncology|May 26, 2020
Postchemotherapy retroperitoneal lymph node dissection in patients presenting with very high HCG levelsRyan W Speir, Adam C Calaway, Lawrence H Einhorn, et al.
European Urology|August 25, 2019
Reply to Gregory J. Nason, Michael A.S. Jewett, and Robert J. Hamilton's Letter to the Editor re: Adam C. Calaway, Lawrence H. Einhorn, Timothy A. Masterson, Richard S. Foster, Clint Cary. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer. Eur Urol 2019;76:607-609: Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular CancerAdam C Calaway, Lawrence H Einhorn, Timothy A Masterson, et al.
Urologic Oncology|October 3, 2018
A novel preoperative model to predict 90-day surgical mortality in patients considered for renal cell carcinoma surgeryAdam C Calaway, M Francesca Monn, Clinton D Bahler, et al.
European Urology|June 9, 2019
Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular CancerAdam C Calaway, Lawrence H Einhorn, Timothy A Masterson, et al.
Urologic Oncology|February 1, 2020
Improving postoperative quality of care in germ cell tumor patients: Does scheduled alvimopan, acetaminophen, and gabapentin improve short-term clinical outcomes after retroperitoneal lymph node dissection?Adam C Calaway, Richard S Foster, Yan Tong, et al.
Pageof 4